Precigen, Inc. (NASDAQ:PGEN) Q4 2024 Earnings Call Transcript
Operator: Good evening, and welcome to the Precigen's Full Year 2024 Financial Results and Business Update Call. At this time, all lines are in listen-only mode.
Precigen Inc. (PGEN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.85 | 58,823 | $49,999.55 | 743,097 | 2024-08-09 | Filing | |
| $0.85 | 23,529,411 | $19,999,999.35 | 64,547,214 | 2024-08-09 | Filing | |
| $1.41 | 96,686 | $136,327.26 | 1,096,686 | 2023-12-28 | Filing | |
| $1.41 | 25,000 | $35,250.00 | 356,836 | 2023-09-22 | Filing | |
| $1.51 | 119,411 | $180,310.61 | 31,837,786 | 2023-08-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.41 | 96,686 | $136,327.26 | 238,275 | 2023-12-28 | Filing | |
| $1.53 | 76,969 | $117,762.57 | 1,560,004 | 2023-08-25 | Filing | |
| $1.64 | 10,947 | $17,953.08 | 428,916 | 2023-08-24 | Filing | |
| $1.64 | 5,388 | $8,836.32 | 133,474 | 2023-08-24 | Filing | |
| $1.64 | 8,891 | $14,581.24 | 458,903 | 2023-08-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
Should You Invest in Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should you Hold Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Precigen, Inc. (NASDAQ:PGEN) Q2 2024 Earnings Call Transcript
Operator: Good evening and welcome to the Precigen’s Second Quarter and First Half 2024 Financial Results Call. At this time, all lines are in a listen-only mode.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript
Precigen, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.08.
Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Ken Griffin, Daniel Och, EDL Capital, Rokos Capital Management, Precigen Inc (PGEN), Sigilon Therapeutics, Inc. (SGTX), and More
George Soros has been branded as a bogeyman by the right wing for backing liberal causes around the globe.
Precigen, Inc. (NASDAQ:PGEN) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Precigen Second Quarter and First Half 2023 Financial Results and Business Update Call. Please note this event is being recorded.
Billionaire Hedge Funds
